Beaumaris, United Kingdom

Gilbert F Woods

This inventor holds 2 USPTO granted patents. Top assignee: Akzo N.v.. Active years: 1981-1993.


% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 1


Location History:

  • Glasgow, GB (1981)
  • Beaumaris, GB (1993)

Company Filing History:


Years Active: 1981-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Gilbert F Woods

Introduction

Gilbert F Woods is a notable inventor based in Beaumaris, GB. He has made significant contributions to the field of immunomodulation and anti-inflammatory treatments. With a total of 2 patents, his work has the potential to impact various therapeutic applications.

Latest Patents

Woods' latest patents include "Pregnane derivatives as immunomodulators." This invention provides novel pregnane derivatives that possess immunomodulating properties. The compounds are characterized by specific formulas that include various halogens and alkyl groups. Another significant patent is "Novel alkylated pregnanes, processes for their preparation and pharmaceutical compositions." This invention relates to 21-alkylated steroids of the pregnane series, which exhibit strong anti-inflammatory properties when applied locally.

Career Highlights

Gilbert F Woods is associated with Akzo N.V., a company known for its innovative solutions in various sectors. His work at Akzo N.V. has allowed him to focus on developing novel compounds that address critical health issues.

Collaborations

Woods has collaborated with notable coworkers, including Robert T Logan and James Cairns. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Gilbert F Woods is a distinguished inventor whose work in immunomodulation and anti-inflammatory treatments showcases his innovative spirit. His contributions through patents reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…